HUL strengthens beauty and personal care market dominance with acquisition of Uprising Science, approved by CCI.

Maltova and Viva from GSK Consumer. Also Read HUL Q4 Results: Profit at Rs 2558 crore, revenue up 24.5% on-year to Rs 15,210 crore The acquisition has undoubtedly added heft to the portfolio.

Hindustan Unilever Limited (HUL) was the undisputed king of India’s stock market, delivering a ~25% CAGR. But in the last ...

GSK Consumer Healthcare said in a statement. The company has already initiated the process of getting approval and has already initiated integration teams, said HUL Chief Financial Officer ...

FMCG major Hindustan Unilever (HUL) is slated to reveal its March quarter earnings on April 24, 2024. Zee Business Research desk estimates the company to report a subdued quarter with revenue seen ...